SCHEMBL4028856

SCHEMBL4028856

COc1ccc(COc2ccccc2CC(=O)O)cc1OCc1nc(-c2ccccc2)oc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.53
KDM4E B2RXH2 1/20 0.52
MAPT P10636 3/20 0.49
KDR P35968 1/20 0.48
CFD P00746 2/20 0.48
F11 P03951 2/20 0.48
TPSB2 P20231 2/20 0.48
PLG P00747 1/20 0.48
PLAU P00749 1/20 0.48
KLKB1 P03952 1/20 0.48
F7 P08709 1/20 0.48
PPARG P37231 5/20 0.47
PPARA Q07869 5/20 0.47
ABCB1 P08183 2/20 0.46
TP53 P04637 1/20 0.46
POLB P06746 1/20 0.46
PPARD Q03181 1/20 0.46
ABCG2 Q9UNQ0 1/20 0.46
SMPD1 P17405 1/20 0.46
THRB P10828 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4033764 0.96 FFAR1 (0.53) FFAR1KDM4EMAPTKDRCFD
SCHEMBL4032386 0.87 FFAR1 (0.49) FFAR1KDM4EMAPTKDRPPARG
SCHEMBL4034630 0.87 FFAR1 (0.68) FFAR1KDM4EMAPTKDRPPARG
SCHEMBL4031209 0.86 KDR (0.62) FFAR1MAPTKDRPPARGPPARA
SCHEMBL4843985 0.86 FFAR1 (0.59) FFAR1KDM4EMAPTKDRPPARG
SCHEMBL5201483 0.86 KDM4E (0.63) FFAR1KDM4EMAPTKDRPPARG
SCHEMBL4031041 0.86 KDR (0.67) FFAR1KDM4EMAPTKDRCFD
SCHEMBL4034488 0.84 FFAR1 (0.62) FFAR1KDM4EMAPTKDRPPARG
SCHEMBL4037707 0.84 FFAR1 (0.54) FFAR1KDM4EPPARGPPARA
SCHEMBL4038084 0.84 FFAR1 (0.58) FFAR1KDM4EPPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1357115-B1 ALKANOIC ACID DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND USE THEREOF TAKEDA PHARMACEUTICAL (JP) 2009-06-17 EP disclosed
US-7238716-B2 Alkanoic acid derivatives process for their production and use thereof TAKEDA PHARMACEUTICALS COMPANY LIMITED (JP) 2007-07-03 US disclosed
US-20040058965-A1 Alkanoic acid derivatives process for their production and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-25 US disclosed
EP-1357115-A1 ALKANOIC ACID DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2003-10-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058965-A1 Alkanoic acid derivatives process for their production and use thereof GPR119, ACOX1, ALK FFAR1 4/4885KDM4E 570/4885MAPT 4719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.